Drugdiscovery >> Clinical Trials >> News
6845
Views
Melflufen enters Phase II study in the treatment of multiple myeloma patients - drugdiscovery.com
Melflufen enters Phase II study in the treatment of multiple myeloma patients - drugdiscovery.com


Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determine the efficacy of the treatment.
Read More >>


Tags: melflufen, J1, multiple myeloma, late stage, clinical trial - August 24, 2013
Related Articles
13399
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

2805
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

5265
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

4483
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

4564
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

3105
Views
Auris medical's first patient entered in Phase III Study for tinnitus Auris medical's first patient entered in Phase III Study for tinnitus
Auris announced that the first patient has entered the clinical trial phase III in Europe. Read More >>

Tags: europe, PhasII, Auris, Tinnitus

6271
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

4938
Views
Tresiba efficient in type 2 diabetes patients - study shows Tresiba efficient in type 2 diabetes patients - study shows
The results of the study demonstrate that Novo Nordisk’s recently launched drug Tresiba (insulin degludec) enables patients with type 2 diabetes to sustain good long-term glycemic control, when used Read More >>

Tags: Tresiba, glycemic control, type 2 diabetes, Novo Nordisk, insulin degludec

3048
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

4041
Views
Leukemia drug Arzerra as a treatment for multiple sclerosis Leukemia drug Arzerra as a treatment for multiple sclerosis
GSK and Genmab drug Arzerra (ofatumumab) has shown potential for reducing the number of new brain lesions in relapsing-remitting MS patients, in a Phase 2 study. Read More >>

Tags: arzerra, GSK, leukemia drug, multiple sclerosis, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013